Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes-Reference-Cited by-同舟云学术

Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes

Published:2010-12 Issue:9757 Volume:376 Page:2000-2008
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Krug Utz,Röllig Christoph,Koschmieder Anja,Heinecke Achim,Sauerland Maria Cristina,Schaich Markus,Thiede Christian,Kramer Michael,Braess Jan,Spiekermann Karsten,Haferlach Torsten,Haferlach Claudia,Koschmieder Steffen,Rohde Christian,Serve Hubert,Wörmann Bernhard,Hiddemann Wolfgang,Ehninger Gerhard,Berdel Wolfgang E,Büchner Thomas,Müller-Tidow Carsten

Publisher

Elsevier BV

Subject

General Medicine

Reference35 articles.

1. Effect of complete remission and responses less than complete remission on survival in acute myeloid leukemia: a combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M D Anderson Cancer Center Study;Walter;J Clin Oncol,2010

2. On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group;Löwenberg;J Clin Oncol,1989

3. Double induction containing either two courses or one course of high-dose cytarabine plus mitoxantrone and postremission therapy by either autologous stem-cell transplantation or by prolonged maintenance for acute myeloid leukemia;Büchner;J Clin Oncol,2006

4. Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome;Kantarjian;Cancer,2006

5. A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group;Rowe;Blood,2004

Cited by 271 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frontline therapy of acute myeloid leukemia with lower intensity regimens: Where are we now and where can we go?;American Journal of Hematology;2024-07-17

2. Regional disparities in the use of intensive chemotherapy for AML in the Netherlands: does it influence survival?;BMJ Oncology;2024-07

3. Breaking down frailty: Assessing vulnerability in acute myeloid leukemia;Blood Reviews;2024-07

4. Advances in Drug Delivery Systems for the Treatment of Acute Myeloid Leukemia;Small;2024-06-27

5. Matrine regulates miR‐495‐3p/miR‐543/PDK1 axis to repress the progression of acute myeloid leukemia via the Wnt/β‐catenin pathway;Chemical Biology & Drug Design;2024-01